Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Benitec Biopharma (BNTC) Assets: 2019-2024

Historic Assets for Benitec Biopharma (BNTC) over the last 6 years, with Jun 2024 value amounting to $52.2 million.

  • Benitec Biopharma's Assets rose 601.44% to $105.2 million in Q1 2025 from the same period last year, while for Mar 2025 it was $105.2 million, marking a year-over-year increase of 601.44%. This contributed to the annual value of $52.2 million for FY2024, which is 1069.58% up from last year.
  • Per Benitec Biopharma's latest filing, its Assets stood at $52.2 million for FY2024, which was up 1,069.58% from $4.5 million recorded in FY2023.
  • In the past 5 years, Benitec Biopharma's Assets registered a high of $52.2 million during FY2024, and its lowest value of $4.5 million during FY2023.
  • In the last 3 years, Benitec Biopharma's Assets had a median value of $6.0 million in 2022 and averaged $20.9 million.
  • As far as peak fluctuations go, Benitec Biopharma's Assets tumbled by 72.06% in 2022, and later skyrocketed by 1,069.58% in 2024.
  • Benitec Biopharma's Assets (Yearly) stood at $11.6 million in 2020, then spiked by 84.51% to $21.4 million in 2021, then plummeted by 72.06% to $6.0 million in 2022, then declined by 25.26% to $4.5 million in 2023, then spiked by 1,069.58% to $52.2 million in 2024.